Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer

  • Authors:
    • S.-P. Changlai
    • S.-C. Tsai
    • M.-C. Chou
    • Y.-J. Ho
    • C.-H. Kao
  • View Affiliations

  • Published online on: March 1, 2001     https://doi.org/10.3892/or.8.2.337
  • Pages: 337-339
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The helpfulness of 18F-2-deoxyglucose positron emission tomography (FDG-PET) in restaging non-small cell lung cancer (NSCLC) has not been extensively evaluated. A total of 156 patients referred for restaging of NSCLC were retrospectively evaluated. According to the classification of American Joint Committee on Cancer, stages I and II were defined as conventionally resectable, stage IIIA as locally advanced but resectable, stage IIIB as locally advanced but unresectable, and stage IV as absolutely unresectable. Compared to initial staging by chest computed tomographic findings, FDG-PET down-staged 45/156 (29%) and up-staged 52/156 (33%) NSCLCs. In addition, 37/156 (23%) patients were reclassified from resectable to unresectable and 22/156 (14%) patients were reclassified from unresectable to resectable. Our results prove the helpfulness of whole body FDG-PET for restaging NSCLC.

Related Articles

Journal Cover

March-April 2001
Volume 8 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Changlai S, Tsai S, Chou M, Ho Y and Kao C: Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer. Oncol Rep 8: 337-339, 2001
APA
Changlai, S., Tsai, S., Chou, M., Ho, Y., & Kao, C. (2001). Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer. Oncology Reports, 8, 337-339. https://doi.org/10.3892/or.8.2.337
MLA
Changlai, S., Tsai, S., Chou, M., Ho, Y., Kao, C."Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer". Oncology Reports 8.2 (2001): 337-339.
Chicago
Changlai, S., Tsai, S., Chou, M., Ho, Y., Kao, C."Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer". Oncology Reports 8, no. 2 (2001): 337-339. https://doi.org/10.3892/or.8.2.337